Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16072241
[patent_doc_number] => 20200190107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => QUINAZOLINE COMPOUND FOR EGFR INHIBITION
[patent_app_type] => utility
[patent_app_number] => 16/474999
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474999 | Quinazoline compound for EGFR inhibition | Dec 28, 2017 | Issued |
Array
(
[id] => 16999431
[patent_doc_number] => 11078222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Hydroxybenzoic acid derivatives, methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/475277
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 13403
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475277 | Hydroxybenzoic acid derivatives, methods and uses thereof | Dec 28, 2017 | Issued |
Array
(
[id] => 16970458
[patent_doc_number] => 11066419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => 1H-pyrrole-2,5-dione compounds and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/474220
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39378
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 418
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474220 | 1H-pyrrole-2,5-dione compounds and methods of using same | Dec 20, 2017 | Issued |
Array
(
[id] => 16807782
[patent_doc_number] => 20210130335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NOVEL BENZOFURAN, BENZOTHIOPHENE, AND INDOLE ANALOGS THAT INHIBIT THE FORMATION OF TAU OLIGOMERS AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 16/471424
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 459
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471424 | Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use | Dec 17, 2017 | Issued |
Array
(
[id] => 16816774
[patent_doc_number] => 11001580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Aminothiazole compounds as c-Kit inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/469517
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25630
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469517 | Aminothiazole compounds as c-Kit inhibitors | Dec 13, 2017 | Issued |
Array
(
[id] => 12624300
[patent_doc_number] => 20180099930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHOD FOR PREPARING AZETIDINONE COMPOUND AND INTERMEDIATE OF AZETIDINONE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/835649
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/835649 | Method for preparing azetidinone compound and intermediate of azetidinone compound | Dec 7, 2017 | Issued |
Array
(
[id] => 12813091
[patent_doc_number] => 20180162867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => EIS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/836666
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 574
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836666 | Eis inhibitors | Dec 7, 2017 | Issued |
Array
(
[id] => 15023253
[patent_doc_number] => 20190322631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 16/469925
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469925
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469925 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | Dec 7, 2017 | Abandoned |
Array
(
[id] => 14088013
[patent_doc_number] => 10239898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Compounds based on adducts with isocyanates for coating compositions
[patent_app_type] => utility
[patent_app_number] => 15/834495
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4733
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15834495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/834495 | Compounds based on adducts with isocyanates for coating compositions | Dec 6, 2017 | Issued |
Array
(
[id] => 13026401
[patent_doc_number] => 10035816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Compound for treating respiratory syncytial virus infection and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/834945
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4946
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15834945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/834945 | Compound for treating respiratory syncytial virus infection and preparation method and use thereof | Dec 6, 2017 | Issued |
Array
(
[id] => 14699965
[patent_doc_number] => 10377715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => 18-20 member bi-polycyclic compounds
[patent_app_type] => utility
[patent_app_number] => 15/833530
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 13483
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833530
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/833530 | 18-20 member bi-polycyclic compounds | Dec 5, 2017 | Issued |
Array
(
[id] => 12790336
[patent_doc_number] => 20180155281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/822930
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 799
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15822930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/822930 | Cytotoxic peptides and conjugates thereof | Nov 26, 2017 | Issued |
Array
(
[id] => 15117023
[patent_doc_number] => 20190345144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => PYRROLIDINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/461475
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461475 | Pyrrolidinone compounds | Nov 26, 2017 | Issued |
Array
(
[id] => 12238381
[patent_doc_number] => 20180071245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TREATMENT OF CIRCADIAN RHYTHM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/822162
[patent_app_country] => US
[patent_app_date] => 2017-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20843
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15822162
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/822162 | Treatment of circadian rhythm disorders | Nov 25, 2017 | Issued |
Array
(
[id] => 13289085
[patent_doc_number] => 10155718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Process to prepare 3-methyl-2-nitrobenzoic acid by air oxidation
[patent_app_type] => utility
[patent_app_number] => 15/819646
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17770
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819646 | Process to prepare 3-methyl-2-nitrobenzoic acid by air oxidation | Nov 20, 2017 | Issued |
Array
(
[id] => 12728458
[patent_doc_number] => 20180134653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => SUBSTITUTED ACETHYDRAZIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/818076
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15818076
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/818076 | Substituted acethydrazide derivative, preparation method and use thereof | Nov 19, 2017 | Issued |
Array
(
[id] => 15573959
[patent_doc_number] => 10577346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof
[patent_app_type] => utility
[patent_app_number] => 16/308790
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27926
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308790 | Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof | Nov 16, 2017 | Issued |
Array
(
[id] => 16842875
[patent_doc_number] => 11014949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Compounds for treatment of senescence-related disorders
[patent_app_type] => utility
[patent_app_number] => 16/465882
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8255
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465882 | Compounds for treatment of senescence-related disorders | Nov 14, 2017 | Issued |
Array
(
[id] => 12862051
[patent_doc_number] => 20180179191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => SYNTHESIS OF A COMPOUND THAT MODULATES THE ACTIVITY OF BROMODOMAIN-CONTAINING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/809296
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809296
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809296 | SYNTHESIS OF A COMPOUND THAT MODULATES THE ACTIVITY OF BROMODOMAIN-CONTAINING PROTEINS | Nov 9, 2017 | Abandoned |
Array
(
[id] => 12205762
[patent_doc_number] => 20180050987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'AROMATIC IONIZABLE CATIONIC LIPID'
[patent_app_type] => utility
[patent_app_number] => 15/799098
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23100
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15799098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/799098 | Aromatic ionizable cationic lipid | Oct 30, 2017 | Issued |